SPONSOR
Huashan Hospital
Total Trials
13
Recruiting
13
Phases
Phase 4, Phase 3
Conditions studied: Alzheimer DiseasePositron Emission TomographySalivary Gland CancersPatient Derived OrganoidDrug Sensitive Test in VitroHemodialysisCognitive ImpairmentCerebrovascular DisordersMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related DisordersTuberculosis
Huashan Hospital is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Alzheimer Disease, Positron Emission Tomography, Salivary Gland Cancers, Patient Derived Organoid.
The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huashan Hospital
How many clinical trials has Huashan Hospital sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Huashan Hospital, of which 13 are actively recruiting participants. These trials cover conditions including Alzheimer Disease, Positron Emission Tomography, Salivary Gland Cancers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huashan Hospital research focus on?
Huashan Hospital clinical trials span Alzheimer Disease, Positron Emission Tomography, Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huashan Hospital clinical trial?
To participate in a Huashan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huashan Hospital trials with current recruitment status updated daily.
Clinical Trials by Huashan Hospital
NCT06827678
Recruiting
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
Alzheimer Disease
NCT06686979
Recruiting
PDO Based Drug Sensitive Test in R/M SGC
Salivary Gland Cancers
NCT04433455
Recruiting
Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
Hemodialysis
NCT06617962
Recruiting
Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders
Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
NCT06153069 Phase 4
Recruiting
Asymptomatic TB With Innovative Modified Short-course Regimens
Tuberculosis
NCT06300879
Recruiting
A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
Gastric Cancer
NCT06553911
Recruiting
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Respiratory Infectious Diseases
NCT06033807
Recruiting
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Tuberculosis
NCT06912282
Recruiting
Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome
Meige Syndrome
NCT05965128
Recruiting
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
Respiratory Infectious Diseases
NCT06994975 Phase 3
Recruiting
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
Acute Ischemic Stroke
NCT04037995
Recruiting
Real World Study of End-stage Liver Disease in China
End Stage Liver DIsease
NCT06102837
Recruiting
Tumor Vaccines for Solid Tumors
Glioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology